Clinical Trial Update: Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Update on a Phase 1/2 clinical trial evaluating a four-drug combination (carfilzomib, lenalidomide, dexamethasone, belantamab mafodotin) for multiple myeloma; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Blenrep (belantamab mafodotin)
• Dexamethasone (Decadron) (dexamethasone)
• Kyprolis (carfilzomib)
• Revlimid (lenalidomide)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING